Urinary tract infections during pregnancy

Annals of Pharmacotherapy

Volumn 38, Issue 10, 2004, Pages 1692-1701

  Le, Jennifer ^a   Briggs, Gerald G ^b   McKeown, Anna ^c   Bustillo, Gerardo ^d  

^a WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

^b LONG BEACH MEMORIAL MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Orange Coast Memorial Medical Center   (United States)

Author keywords

Bacteriuria; Cystitis; Gestation; Pregnancy; Pyelonephritis; Urinary tract infection

Indexed keywords

AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; CEFALEXIN; CEFALOTIN; CEFAZOLIN; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; FOSFOMYCIN; GENTAMICIN; NITROFURANTOIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFONAMIDE; TETRACYCLINE DERIVATIVE; VANCOMYCIN;

ANEMIA; ANTIBIOTIC RESISTANCE; ASYMPTOMATIC BACTERIURIA; BACTERIAL INFECTION; COCHRANE LIBRARY; CYSTITIS; DIAGNOSTIC VALUE; DISEASE SEVERITY; DRUG SAFETY; ENTEROBACTERIACEAE; EVALUATION; FEMALE; FETUS MORTALITY; FETUS OUTCOME; HUMAN; KIDNEY FAILURE; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; MORBIDITY; MORTALITY; OUTCOMES RESEARCH; PERINATAL CARE; PREECLAMPSIA; PREGNANCY COMPLICATION; PREMATURE LABOR; PRIORITY JOURNAL; PYELONEPHRITIS; REVIEW; THROMBOCYTOPENIA; URINARY TRACT INFECTION;

AMBULATORY CARE; ANTI-INFECTIVE AGENTS, URINARY; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; URINARY TRACT INFECTIONS;

EID: 4644310403     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1D630     Document Type: Review

References (96)

1. Cunningham FG, Lucas MJ. Urinary tract infections complicating pregnancy. Baillieres Clin Obstet Gynaecol 1994;8:353-73.
2. Conolly A, Thorp JM. Urinary tract infections in pregnancy. Urol Clin North Am 1999;26:779-87.
3. Wing DA. Pyelonephritis in pregnancy: treatment options for optimal outcomes. Drugs 2001;61:2087-96.
4. Levinson W, Jawetz E. Medical microbiology and immunology. 6th ed. New York: Lange Medical Books/McGraw-Hill, 2000:26.
5. North DH, Speed JE, Weinter WB, Morrison JC. Correlation of urinary tract infection with urinary screening at the first antepartum visit. J Miss State Med Assoc 1990;31:331-3.
6. Andrews WW, Gilstrap LC. Urinary tract infections. In: Gleicher N, Buttino L, eds. Principles and practice of medical therapies in pregnancy. 3rd ed. Stamford, CT: Appleton and Lange, 1998:913-7.
7. Duff P. Pyelonephritis in pregnancy. Clin Obstet Gynecol 1984;27:17-31.
8. Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med 2002;113(suppl 1A):5S-13S.
9. Bint AJ, Hill D. Bacteriuria of pregnancy-an update on significance, diagnosis, and management. J Antimicrob Chemother 1994;33(suppl A):93-7.
10. Kingingham RB. Asymptomatic bacteriuria in pregnancy. Am Fam Physician 1993;47:1232-8.
11. Gilstrap LC 3rd, Cunningham FG, Whalley PJ. Acute pyelonephritis in pregnancy: an anterospective study. Obstet Gynecol 1981;57:409-13.
12. Martinell J, Claesson I, Lidin-Janson G, Jodal U. Urinary infection, reflux and renal scarring in females continuously followed for 13-18 years. Pediatr Nephrol 1995;9:131-6.
13. Gilstrap LC, Ramin SM. Urinary tract infections during pregnancy. Obstet Gynecol Clin North Am 2001;28:581-91.
14. Delzell JE, Lefevre ML. Urinary tract infections during pregnancy. Am Fam Physician 2000;61:713-21.
15. Patterson TF, Andriole VT. Bacteriuria in pregnancy. Infect Dis Clin North Am 1987;1:807-22.
16. Andriole VT, Patterson TF. Epidemiology, natural history, and management of urinary tract infections in pregnancy. Med Clin North Am 1991;75:359-73.
17. McNeeley SG. Treatment of urinary tract infections during pregnancy. Clin Obstet Gynecol 1988;31:480-7.
18. Pastore LM, Savitz DA, Thorp JM Jr, Koch GG, Hertz-Picciotto I, Irwin DE. Predictors of symptomatic urinary tract infection after 20 weeks' gestation. J Perinatol 1999;19:488-93.
19. McMahon MJ, Ananth CV, Liston RM. Gestational diabetes mellitus. Risk factors, obstetrics complications and infant outcomes. J Reprod Med 1998;43:372-8.
20. Sobczak M, Wilczynski J, Cypryk K, Woch G. [Bacterial flora in infections of the urinary system in pregnant women with pre-gestational diabetes] Polish. Ginekol Pol 1999;70:725-31.
21. Pasture LM, Savitz DA, Thorp JM. Predictors of urinary tract infection at the first prenatal visit. Epidemiology 1999;10:282-7.
22. Campbell-Brown M, McFadyen IR, Seal DV, Stephenson ML. Is screening for bacteriuria in pregnancy worth while? Br Med J (Clin Res Ed) 1987;294:1579-82.
23. Ovalle A, Levancini M. Urinary tract infections in pregnancy. Curr Opin Urol 2001;11:55-9.
24. Gilstrap LC. Urinary tract infections in women. Curr Opin Obstet Gynecol 1989;1:31-4.
25. Lucas MJ, Cunningham FG. Urinary tract infection during pregnancy. Clin Obstet Gynecol 1993;36:855-68.
26. Patterson FT, Andriole VT. Detection, significance, and therapy of bacteriuria in pregnancy. Infect Dis Clin North Am 1997;11:593-608.
27. Mead PJ, Harris RE. The incidence of group B beta hemolytic streptococcus in antepartum urinary tract infections. Obstet Gynecol 1978;51:412-4.
28. Pass MA, Gray BM, Dillion HC Jr. Puerperal and perinatal infections with group B streptococci. Am J Obstet Gynecol 1982;143:147-52.
29. Thomsen AC, Morup L, Hansen KB. Antibiotic elimination of group B streptococci in urine in prevention of preterm labour. Lancet 1987;1:591-3.
30. Prevention of perinatal group B streptococcal disease: revised guidelines from Centers for Disease Control and Prevention. MMWR Morbid Mortal Wkly Rep 2002;51(RR-11):1-28.
31. American College of Obstetricians and Gynecologists Committee on Obstetric Practice: prevention of early-onset group B streptococcal disease in newborns. ACOG Committee Opinion, no. 279. Washington, DC, American College of Obstetricians and Gynecologists, 2002.
32. Svanborg C, Godalay G. Bacterial virulence in urinary tract infection. Infect Dis Clin North Am 1997;11:513-29.
33. Latham RH, Stamm WE. Role of fimbriated Escherichia coli in urinary tract infections in adult women: correlation with localization studies. J Infect Dis 1984;149:835-40.
34. O'Hanley P, Low D, Romero I, Lark D, Vosti K, Falkow S, Schoolnik G. Gal-Gal binding and hemolysin phenotypes and genotypes associated with uropathogenic Escherichia coli. N Engl J Med 1985;313:414-20.
35. Hooton TM, Stamm WE. Diagnosis and treatment of uncomplicated urinary tract infection. Infect Dis Clin North Am 1997;11:551-81.
36. McCarty JM, Richard G, Huck W, Tucker RM, Tosiello RL, Shan M, et al. A randomized trial of short-course ciprofloxacin, ofloxacin, or trimethoprim/sulfamethoxazole for the treatment of acute urinary tract infection in women. Ciprofloxacin Urinary Tract Infection Group. Am J Med 1999;106:292-9.
37. Masterton RG, Bochsler JA. High-dosage co-amoxiclav in a single dose versus 7 days of co-trimoxazole as treatment of uncomplicated lower urinary tract infection in women. J Antimicrob Chemother 1995;35:129-37.
38. Wright SW, Wrenn KD, Haynes ML. Trimethoprim-sulfamethoxazole resistance among urinary coliform isolates. J Gen Intern Med 1999;14:606-9.
39. Steinke DT, Seaton RA, Phillips G, MacDonald TM, Davey PG. Factors associated with trimethoprim-resistant bacteria isolated from urine samples. J Antimicrob Chemother 1999;43:841-3.
40. Reves RR, Fong M, Pickering LK, Bartlett A 3rd, Alvarez M, Murray BE. Risk factors for fecal colonization with trimethoprim-resistant and multiresistant Escherichia coli among children in day-care centers in Houston, Texas. Antimicrob Agents Chemother 1990;34:1429-34.
41. Manges AR, Johnson JR, Foxman B, O'Bryan TT, Fullerton KE, Riley LW. Widespread distribution of urinary tract infections caused by a multidrug-resistant Escherichia coli clonal group. N Engl J Med 2001;345:1007-13.
42. Gupta K, Scholes D, Stamm WE. Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women. JAMA 1999;281:736-8.
43. Gupta K, Hooton TM, Stamm WE. Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections. Ann Intern Med 2001;135:41-50.
44. Sahm DF, Thornsberry C, Mayfield DC, Jones ME, Karlowsky JA. Multidrug-resistant urinary tract isolates of Escherichia coli: prevalence and patient demographics in the United States in 2000. Antimicrob Agents Chemother 2001;45:1402-6.
45. Karlowsky JA, Thornsberry C, Jones ME, Sahm DF. Susceptibility of antimicrobial-resistant urinary Escherichia coli isolates to fluoroquinolones and nitrofurantoin. Clin Infect Dis 2003;36:183-7.
46. Mathai D, Jones RN, Pfaller MA, SENTRY Participant Group North America. Epidemiology and frequency of resistance among pathogens causing urinary tract infections in 1,510 hospitalized patients: a report from the SENTRY Antimicrobial Surveillance Program (North America). Diagn Microbiol Infect Dis 2001;40:129-36.
47. Schieve LA, Handler A, Hershow R, Persky V, Davis F. Urinary tract infection during pregnancy: its association with maternal morbidity and perinatal outcome. Am J Public Health 1994;84:405-10.
48. Gilstrap LC, Leveno KJ, Cunningham FG, Whalley PJ, Roark ML. Renal infection and pregnancy outcome. Am J Obstet Gynecol 1981;141:709-16.
49. Romero R, Oyarzun E, Mazor M, Sirtori M, Hobbins JC, Bracken M. Meta-analysis of the relationship between asymptomatic bacteriuria and preterm delivery/low birth weight. Obstet Gynecol 1989;73:576-82.
50. Whalley PJ, Cunningham FG, Martin FG. Transient renal dysfunction associated with acute pyelonephritis of pregnancy. Obstet Gynecol 1975;46:174-7.
51. Cunningham FG, Lucas MJ, Hankins GDV. Pulmonary injury complicating antepartum pyelonephritis. Am J Obstet Gynecol 1987;156:797-807.
52. Towers CV, Kaminskas CM, Garite TJ, Nageotte MP, Dorchester W. Pulmonary injury associated with antepartum pyelonephritis: can patients at risk be identified? Am J Obstet Gynecol 1991;164:974-80.
53. Sobel JD, Kaye D. Urinary tract infections. In: Mandell GL, Bennet JE, Dolin R, eds. Principles and practice of infectious diseases. 5th ed. New York: Churchill Livingstone, 2002:773-805.
54. Stamm WE, Hooton TM. Management of urinary tract infections in adults. N Engl J Med 1993;329:1328-34.
55. Rubin RH, Shapiro ED, Andriole VT, Davis RJ, Stamm WE. Evaluation of new anti-infective drugs for the treatment of urinary tract infection. Clin Infect Dis 1992;15(suppl 1):S216-27.
56. Zhanel GG, Harding GK, Guay DR. Asymptomatic bacteriuria: which patients should be treated? Arch Intern Med 1990;150:1389-96.
57. Stamm WE, Hooton TM, Johnson JR, Johnson C, Stapleton A, Roberts PL, et al. Urinary tract infections from pathogenesis to treatment. J Infect Dis 1989;159:400-6.
58. Lifshitz E, Kramer L. Outpatient urine culture: does collection technique matter? Arch Intern Med 2000;160:2537-40.
59. Bachman JW, Heise RH, Naessens JM, Timmerman MG. A study of various tests to detect asymptomatic urinary tract infections in an obstetric population. JAMA 1993;270:1971-4.
60. Millar L, DeBuque L, Leialoha C, Grandinetti A, Killeen J. Rapid enzymatic urine screening test to detect bacteriuria in pregnancy. Obstet Gynecol 2000;95:601-4.
61. Stamm WE. Urinary tract infections and pyelonephritis. In: Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DL, et al., eds. Harrison's principles of internal medicine. 14th ed. New York: McGraw-Hill, 1998:817-23.
62. Jou WW, Powers RD. Utility of dipstick urinalysis as a guide to management of adults with suspected infection or hematuria. South Med J 1998;91:266-9.
63. MacMillan MC, Grimes DA. The limited usefulness of urine and blood cultures in treating pyelonephritis in pregnancy. Obstet Gynecol 1991;78:745-8.
64. Wing DA, Park AS, DeBuque L, Millar LK. Limited clinical utility of blood and urine cultures in the treatment of acute pyelonephritis during pregnancy. Am J Obstet Gynecol 2000;182:1437-41.
65. Bates DW, Cook EF, Goldman L. Predicting bacteremia in hospitalized patients. A prospectively validated model. Ann Intern Med 1990;113:495-500.
66. Antimicrobial therapy for obstetric patients. ACOG educational bulletin no. 245. Washington, DC: American College of Obstetricians and Gynecologists, 1998;245(Mar):8-10.
67. US Preventive Services Task Force. Guide to clinical preventive services: report of the US Preventive Services Task Force. 2nd ed. Baltimore: Williams & Wilkins, 1996. www.ahcpr.gov/clinic/cpsix.htm#infectious (accessed 2003 Apr 20).
68. Stenqvist K, Dahlen-Nilsson I, Lidin-Janson G, Lincoln K, Oden A, Rignell S, et al. Bacteriuria in pregnancy: frequency and risk of acquisition. Am J Epidemiol 1989;129:372-9.
69. Rouse DJ, Andrews WW, Goldenberg RL, Owen J. Screening and treatment of asymptomatic bacteriuria of pregnancy to prevent pyelonephritis: a cost-effectiveness and cost-benefit analysis. Obstet Gynecol 1995;86:119-23.
70. Wadland WC, Plante DA. Screening for asymptomatic bacteriuria in pregnancy. A decision and cost analysis. J Fam Pract 1989;29:372-6.
71. Wing DA, Hendershott CM, Debuque L, Millar LK. A randomized trial of three antibiotic regimens for the treatment of pyelonephritis in pregnancy. Obstet Gynecol 1998;92:249-53.
72. Jones HC. Intrauterine ototoxicity. A case report and review of the literature. J Natl Med Assoc 1973;65:201-3.
73. Donald PR, Sellars SL. Streptomycin toxicity in the unborn child. S Afr Med J 1981;60:316-8.
74. Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation. 6th ed. Baltimore: Williams & Wilkins, 2002.
75. Christensen B. Which antibiotics are appropriate for treating bacteriuria in pregnancy? J Antimicrob Chemother 2000;46(suppl S1):29-34.
76. Schrag S, Gorwitz R, Fultz-Butts K, Schuchat A. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Morbid Mortal Wkly Rep Recomm Rep 2002;51(RR-11):1-22.
77. Stein GE. Single-dose treatment of acute cystitis with fosfomycin tromethamine. Ann Pharmacother 1998;32:215-9. DOI 10.1345/aph.17227
78. Smaill F. Antibiotics for asymptomatic bacteriuria in pregnancy. (Cochrane Review). In: The Cochrane Library, Issue 2, 2001. Oxford: Update Software.
79. Masterton RG, Evans DC, Strike PW. Single-dose amoxicillin in the treatment of bacteriuria in pregnancy and the puerperium-a controlled clinical trial. Br J Obstet Gynaecol 1985;92:498-505.
80. Harris RE, Gilstrap LC, Pretty A. Single-dose antimicrobial therapy for asymptomatic bacteriuria during pregnancy. Obstet Gynecol 1982;59:546-9.
81. Campbell-Brown M, McFadyen IR. Bacteriuria in pregnancy treated with a single dose of cephalexin. Br J Obstet Gynaecol 1983;90:1054-9.
82. Jakobi P, Neiger R, Merzbach D, Paldi E. Single-dose antimicrobial therapy in the treatment of asymptomatic bacteriuria in pregnancy. Am J Obstet Gynecol 1987;156:1148-52.
83. Villar J, Lydon-Rochelle MT, Gulmezoglu AM, Roganti A. Duration of treatment for asymptomatic bacteriuria during pregnancy (Cochrane Review). In: The Cochrane Library, Issue 2, 2000. Oxford: Update Software.
84. Vasquez JC, Villar J. Treatments for symptomatic urinary tract infections during pregnancy (Cochrane Review). In: The Cochrane Library, Issue 4, 2003. Oxford: Update Software.
85. Angel JL, O'Brien WF, Finan MA, Morales WJ, Lake M, Knuppel RA. Acute pyelonephritis in pregnancy: a prospective study of oral versus intravenous antibiotic therapy. Obstet Gynecol 1990;76:28-32.
86. Loughlin KR. Management of urologic problems during pregnancy. Urology 1994;44:159-69.
87. Brooks AM, Gante TG. Clinical trial of the outpatient management of pyelonephritis in pregnancy. Inf Dis Obstet Gynecol 1995;3:50-5.
88. Millar LK, Wing DA, Paul RH, Grimes DA. Outpatient treatment of pyelonephritis in pregnancy: a randomized controlled trial. Obstet Gynecol 1995;86(4pt 1):560-4.
89. Sanchez-Ramos L, McAlpine KJ, Adair CD, Kaunitz AM, Delke I, Briones DK. Pyelonephritis in pregnancy: once-a-day ceftriaxone versus multiple doses of cefazolin: a randomized, double-blind trial. Am J Obstet Gynecol 1995;172(1 pt 1):129-33.
90. Wing DA, Hendershott CM, Debuque L, Millar LK. Outpatient treatment of acute pyelonephritis in pregnancy after 24 weeks. Obstet Gynecol 1999;94(5 pt 1):683-8.
91. Pfau A, Sacks TG. Effective prophylaxis for recurrent urinary tract infections during pregnancy. Clin Infect Dis 1992;14:810-4.
92. Diokno AC, Compton A, Seski J, Vinson R. Urologic evaluation of urinary tract infection in pregnancy. J Reprod Med 1986;31:23-6.
93. Stothers L. A randomized trial to evaluate effectiveness and cost effectiveness of naturopathic cranberry products as prophylaxis against urinary tract infection in women. Can J Urol 2002;9:1558-62.
94. Kontiokari T, Sundqvist K, Nuutinen M, Pokka T, Koskela M, Uhari M. Randomised trial of cranberry-lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women (letter). BMJ 2001;322:1571.
95. Foo LY, Lu Y, Howell AB, Vorsa N. A-Type proanthocyanidin trimers from cranberry that inhibit adherence of uropathogenic P-fimbriated Escherichia coli. J Nat Prod 2000;63:1225-8.
96. Smaill F. Intrapartum antibiotics for group B streptococcal colonisation (Cochrane Review). In: The Cochrane Library, Issue 2, 2000. Oxford: Update Software.